Patent Assignment
Reel/Frame 059571/0415
Assignment of Assignor's Interest
Recorded: 2022-04-12
Pages: 7
Assignors
BEARSS, DAVID JAMES
Executed: 2022-03-25
KAUWE, JOHN SAI KEONG
Executed: 2022-03-25
MOLLARD, ALEXIS HENRI ABEL
Executed: 2022-03-25
Assignee
HALIA THERAPEUTICS, INC.
1865 W 2100 S, SUITE 100, SALT LAKE CITY, UTAH, 84119
Covered Property
(1)
Inhibitors of LRRK2 Kinase
Patent:
11,578,061 →
Application:
17/702,600 →
Publication:
US 2022/0324845
PCT:
PCT/US2022/021573 ↗